FDA recall D-0112-2025

Lannett Company Inc. · Class II · drug

Product

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

Reason for recall

Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2024-10-25
Report date
2024-12-11
Termination date
2025-06-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Seymour, IN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0112-2025